Analysis of p53, K-ras gene mutation & Helicobacter pylori infection in patients with gastric cancer & peptic ulcer disease at a tertiary care hospital in north India

Indian Journal of Medical Research

Volumn 136, Issue 4, 2012, Pages 664-670

  Saxena, Ashish ^a   Shukla, Sanket Kumar ^b   Prasad, Kashi Nath ^b   Ghoshal, Uday Chand ^b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Gastric cancer; Gene mutations; Helicobacter pylori; Peptic ulcer disease

Indexed keywords

K RAS PROTEIN; PROTEIN P53;

ADULT; ARTICLE; DIGESTIVE TRACT ENDOSCOPY; EXON; FRAMESHIFT MUTATION; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; HELICOBACTER INFECTION; HISTOPATHOLOGY; HUMAN; INDIA; MAJOR CLINICAL STUDY; PEPTIC ULCER; POINT MUTATION; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH ADENOCARCINOMA; STOMACH CANCER; TERTIARY HEALTH CARE;

DNA PRIMERS; GENES, RAS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MUTATION; PEPTIC ULCER; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; SEQUENCE ANALYSIS, DNA; STOMACH NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84869062795     PISSN: 09715916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001; 345: 784-9.
2. International Agency for Research on Cancer. Schistosomes, liver flukes and Helicobacter pylori. IARC Monogr Eval Carcinog Risk Hum 1994; 61: 177-241.
3. Saxena A, Prasad KN, Ghoshal UC, Bhagat MR, Krishnani N, Husain N. Polymorphism of-765G > C COX-2 is a risk factor for gastric adenocarcinoma and peptic ulcer disease in addition to H. pylori infection: a study from northern India. World J Gastroenterol 2008; 14: 1498-503.
4. El-Omar EM, Chow WH, Rabkin CS. Gastric cancer and H. pylori: Host genetics open the way. Gastroenterology 2001; 121: 1002-4.
5. Weinberg RA. Tumor suppressor genes. Science 1991; 254: 1138-46.
6. Sarbia M, Porschen R, Borchard F, Horstmann O, Willirs R, Gobbert HE. p53 protein expression and prognosis in squamous cell carcinoma of the esophagus. Cancer 1994; 74: 2218-23.
7. Renault B, Van den Broek M, Fodde R, Wijmen J, Pellegata NS, Amadori D, et al. Base transitions are the most frequent genetic changes at p53 in gastric cancer. Cancer Res 1993; 53: 2614-7.
8. Petitjean A, Mathe E, Kato S, Ishioka C, Tavtigian SV, Hainaut P, et al. Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database. Hum Mutat 2007; 28: 622-9.
9. Soh K, Yanagisawa A, Hiratsuka H, Sugano H, Kato Y. Variation in K-ras codon 12 point mutation rate with histological atypia within individual colorectal tumors. Jpn J Cancer Res 1993; 84: 388-93.
10. Lee KH, Lee JS, Suh C, Kim SW, Kim SB, Lee JH, et al. Clinicopathological significance of the K-ras gene codon 12 point mutation in stomach cancer. An analysis of 140 cases. Cancer 1995; 75: 2794-801.
11. Capon DJ, Seeburg PH, McGrath JP, Hayflick JS, Edman U, Levinson AD, et al. Activation of Ki-ras 2 gene in human colon and lung carcinoma by two different point mutations. Nature 1983; 304: 507-13.
12. Thillainayagam AV, Arvind AS, Cook RS, Harrison IG, Tabaqchali S, Farthing MJ. Diagnostic efficiency of an ultra rapid endoscopy room test for Helicobacter pylori. Gut 1991; 32: 467-9.
13. Sharma S, Prasad KN, Chamoli D, Ayyagari A. Antimicrobial susceptibility and biotyping pattern of Helicobacter pylori isolates from patients with peptic ulcer diseases. Indian J Med Res 1995; 102: 261-6.
14. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996; 20: 1161-81.
15. Clayton CL, Kleanthous H, Coates PJ, Morgan DD, Tabaqchali S. Sensitive detection of Helicobacter pylori by using polymerase chain reaction. J Clin Microbiol 1992; 30 192-200.
16. Shiao YH, Rugge M, Correa P, Lehmann HP, Scheer WD. p53 alteration in gastric precancerous lesions. Am J Pathol 1994; 144: 511-7.
17. Singh MK, Chetri K, Pandey UB, Kapoor VK, Mittal B, Choudhuri G. Mutational spectrum of K-ras oncogene among Indian patients with gallbladder cancer. J Gastroenterol Hepatol 2004; 19: 916-21.
18. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990; 61: 759-67.
19. May P, May E. Twenty years of p53 research: structural and functional aspects of the p53 protein. Oncogene 1999; 18: 7621-36.
20. Chen PL, Chen YM, Bookstein R, Lee WH. Genetic mechanisms of tumor suppression by the human p53 gene. Science 1990; 250: 1576-80.
21. Mattar R, Nonogaki S, Silva C, Alves V, Gama-Rodrigues JJ. P53 and Rb tumor suppressor gene alterations in gastric cancer. Rev Hosp Clin Fac Med Sao Paulo 2004; 59: 172-80.
22. Fenoglio-Preiser CM, Wang J, Stemmermann GN, Noffsinger A. TP53 and gastric carcinoma: a review. Hum Mutat 2003; 21: 258-70.
23. Murakami K, Fujioka T, Okimoto T, Mitsuishi Y, Oda T, Nishizono A, et al. Analysis of p53 gene mutations in Helicobacter pylori-associated gastritis mucosa in endoscopic biopsy specimens. Scand J Gastroenterol 1999; 34: 474-7.
24. Wang J, Chi DS, Kalin GB, Sosinski C, Miller LE, Burja I, et al. Helicobacter pylori infection and oncogene expressions in gastric carcinoma and its precursor lesions. Dig Dis Sci 2002; 47: 107-13.
25. Lima VP, de Lima MA, André AR, Ferreira MV, Barros MA, Rabenhorst SH. H. pylori (CagA) and Epstein-Barr virus infection in gastric carcinomas: correlation with p53 mutation and c-Myc, Bcl-2 and Bax expression. World J Gastroenterol 2008; 14: 884-91.
26. Hongyo T, Buzard GS, Palli D, Weghorst CM, Amorosi A, Galli M, et al. Mutations of the K-ras and p53 genes in gastric adenocarcinomas from a high-incidence region around Florence, Italy. Cancer Res 1995; 55: 2665-72.
27. Watari J, Tanaka A, Tanabe H, Sato R, Moriichi K, Zaky A, et al. K-ras mutations and cell kinetics in Helicobacter pylori associated gastric intestinal metaplasia: a comparison before and after eradication in patients with chronic gastritis and gastric cancer. J Clin Pathol 2007; 60: 921-6.
28. Hiyama T, Haruma K, Kitadai Y, Masuda H, Miyamota M, Tanaka S, et al. K-ras mutation in Helicobacter pylori associated chronic gasstritis in patients with and without gastric cancer. Int J Cancer 2002; 97: 562-6.
29. Kasper HU, Schneider-Stock R, Mellin W, Roessner A. P21 protein expression and ras-oncogene mutations in gastric carcinoma: correlation with clinical data. Int J Oncol 1998; 12: 69-74.
30. Craanen ME, Blok P, Top B, Boerrigter L, Dekker W, Offerhaus GJ, et al. Absence of ras gene mutations in early gastric carcinomas. Gut 1995; 37: 758-62.